Dahai Dong

585 citations
20 papers · 447 indexed · h-index 13
Topics
Ferroptosis and cancer prognosis (4 papers)Renal cell carcinoma treatment (3 papers)Bladder and Urothelial Cancer Treatments (3 papers)
Partner nations
China

In The Last Decade

Dahai Dong

19 papers receiving 443 citations

Peers

Dahai Dong
Comparison fields: 5 of 74
  • Molecular Biology 218
  • Cancer Research 177
  • Pulmonary and Respiratory Medicine 129
  • Oncology 107
  • Surgery 100
Replace Alin Ji with:
Alin Ji China
Jinna Wu China
Shouzhen Chen China
Guang‐Yan Yu China
Kuiqing Li China
Yu-Ching Wen Taiwan
Sohachi Nanjo Japan
Mao‐Min Song China
Tomoyuki Koguchi Japan
Dahai Dong relative to Alin Ji China Alin Ji's profile →
Citations per field
00.5×1.5×1.8×
Alin Ji · 1×
Citations per year

Countries citing papers authored by Dahai Dong

Since Specialization
Citations

This map shows the geographic impact of Dahai Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dahai Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dahai Dong more than expected).

Fields of papers citing papers by Dahai Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dahai Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dahai Dong. The network helps show where Dahai Dong may publish in the future.

Co-authorship network of co-authors of Dahai Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Dahai Dong. A scholar is included among the top collaborators of Dahai Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dahai Dong. Dahai Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 0
3 19
4 48
5 7
6 46
7 8
8 35
9 12
10 53
11
Protective effects of the AKT activator SC79 on renal ischemia-reperfusion injury.
3
12 17
13 15
14 16
15 19
16 8
17 64
18 16
19 47
20
Effect of anti-P-selectin monoclonal antibody on renal ischemia/reperfusion injury in rats.
7

About Dahai Dong

Dahai Dong is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Immunology and Allergy, having authored 20 papers that have together received 447 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (4 papers), Renal cell carcinoma treatment (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). The work is most often cited by research in Cancer Research (177 citations), Pulmonary and Respiratory Medicine (129 citations) and Oncology (107 citations). Dahai Dong has collaborated with scholars based in China. Frequent co-authors include Guiming Zhang, Lijiang Sun, Yonghua Wang, Xiaokun Yang, Jun Zhao, Lingling Sun, Lei Luo, Wen Liu, Yongfang Jiang and Jirong Wang. Their work appears in journals such as Biomaterials, Journal of Controlled Release and European Spine Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026